Table 1.
Clinical features of the two hepatoblastoma patients.
| Patient 1 (III-1, Older) |
Patient 2 (III-2, Younger) |
|
|---|---|---|
| Gender | Male | Male |
| Age at diagnosis (months) | 15 | 12 |
| Tumor stagea | I | III |
| Tumor size (cm) | 6.2 × 6.2 × 5.5 | 7.7 × 7.2 × 5.1 |
| Metastasis | No | No |
| Risk stratification | Low risk | Average risk |
| SIOPEL classification | Hybrid fetal and embryonic type | Hybrid fetal and embryonic type |
| HBV markers | HBsAb positive | HBsAb positive |
| AFP (IU/mL) | 1000 | 3439 |
| Prognosis | Deceased | Deceased |
aAccording to the PRE-Treatment Extent of tumor (PRETEXT) grouping system.